Journals / İstanbul Medical Journal / 2017 / Cilt: 18 - Sayı: 2

A Patient with Asymptomatic Connective Tissue Disease Coursing with Angioedema

Anjioödemle Seyreden Asemptomatik Bağ Dokusu Hastalığı

Pages
94–96
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The possibility of collagen tissue disease, especially SLE not reflected in the clinic in our case, is strong.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Here we present the case of a patient who was diagnosed with non-familial angioedema (AE) and who had a high risk of connective tissue disease.
📊
Key Findings & Data:C1 inhibitor level was found to be borderline low, and the antinuclear antibody (ANA) level was significantly high.
💡
Conclusion & Impact:The possibility of collagen tissue disease, especially SLE not reflected in the clinic in our case, is strong.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Here we present the case of a patient who was diagnosed with non-familial angioedema (AE) and who had a high risk of connective tissue disease. The patient had recurrent AE and arthritis attacks. C1 inhibitor level was found to be borderline low, and the antinuclear antibody (ANA) level was significantly high. The patient is being followed up with an antihistaminic treatment. The association of AE with systemic lupus erythematosus (SLE) is a rare condition. The possibility of collagen tissue disease, especially SLE not reflected in the clinic in our case, is strong.

Özet

Biz burada ailesel olmayan anjioödem (AE) tanısı alan ve bağ dokusu hastalığı riski yüksek bir olguyu sunduk. Hastada tekrarlayan AE ve art- rit atakları mevcuttu. C1 inhibitör (inh.) düzeyi sınırda düşük bulundu ve beraberinde Anti-Nükleer Antikor (ANA) düzeyi anlamlı yüksekti. An- tihistaminik tedavi ile takip ediliyor. AE ve Sistemik Lupus Eritemasus (SLE) birlikteliği nadir görülen bir durum olarak bilinmektedir. Bizim olgumuzdaki C1 inh. düzeyi düşük AE vakasında kliniğe yansımayan SLE başta olmak üzere kollagen doku hastalığı şüphesi kuvvetlidir.

🔖

Cite This Article

TAŞDEMİR, E., GÜRLEK, F. (2022). A Patient with Asymptomatic Connective Tissue Disease Coursing with Angioedema. İstanbul Medical Journal, Cilt: 18 - Sayı: 2, 94–96. https://ajindex.com/articles/552104

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Cacoub P, Fremeaux-Bacchi V, De Lacroix I, Guillien F, Kahn MF, Kazatchkine MD, et al. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 1836-40. [CrossRef] 2. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, et al. Nonallergic angioedema: role of bradykinin. Allergy 2007; 62: 842-56. [CrossRef] 3. Banerji A, Sheffer AL. The spectrum of chronic AE and Allergy. Asthma Proc 2009; 30: 11-6. [CrossRef] 4. Delves PJ. AE. In:Porter RS, editor. Immunology Allergic disorders. Merck Manual Professional Edition.
  2. Kenilworth, NJ:Merck Sharp & Dohme Co. Inc; 2015.p.1-5. 5. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angiooedema: A review of 554 patients. Br J Dermatol 1969; 81: 588-97. [CrossRef] 6. Sànchez BM, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, et al. Diagnosis and treatment of urticaria and AE: a world wide perspective. World Allergy Organ J 2012; 5: 125-47. [CrossRef] 7. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi C, et al. AE without urticaria: a large clinical survey. CMAJ 2006; 175: 1065-70. [CrossRef] 8. Kaplan AP, Greaves MW. Angioedema. JAAD 2005; 53: 373-92. [CrossRef] 9. Bas M, Hoffmann TK, Kojda G. Evaluation and management of AE of the head and neck. Curr Opin Otolayngol Head Neck Surg 2006; 14: 170-5. [CrossRef] 10. Geha RS, Quinti I, Austen KF, Cicardi M, Sheffer A, Rosen FS. Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulin. N Engl J Med 1985; 312: 534-40. [CrossRef]